Effect of antiamyloid-β drugs on Alzheimer’s disease: study protocol for a systematic review and meta-analysis
Introduction Alzheimer’s disease (AD) is a neurodegenerative disease with a complex aetiology involving multiple targets and pathways. With the continuous growth of the ageing population, the burden of AD is increasing year by year. However, there has not been new drug approved for over a decade. In...
| Published in: | BMJ Open |
|---|---|
| Main Authors: | , , |
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2021-05-01
|
| Online Access: | https://bmjopen.bmj.com/content/11/5/e048453.full |